Zymeworks Announces Strategic Initiative to Optimize Value of Licensed Products by Building a Diversified Portfolio of Revenue-Generating Assets Notified -
AI-Media and AVE Announce Exclusive Partnership to Power Accessibility Across Australia’s Live Events Notified -
Meltwater Named a Leader in IDC MarketScape: Worldwide Influencer Marketing Platforms for Large Enterprises 2025-2026 Vendor Assessment Notified -
MicroEJ and Boon Logic Partner to Simplify Edge AI with Unsupervised Learning for All Embedded Devices Notified -
Bitget Legal Team Wins Multiple 2025 Honours from LexisNexis and Thomson Reuters Asian Legal Business Notified -
VCI Global Declares Special Dividend of V Gallant Shares as Cybersecurity & AI Subsidiary Prepares for Nine-Figure Nasdaq IPO Notified -
MBAK Energy Solutions Inc begins the manufacturing of BESS (Battery Energy Storage System) Power cells for Indian power grid Notified -
Zymeworks Announces Positive HERIZON-GEA-01 Phase 3 Results Supporting Ziihera® (zanidatamab-hrii) as HER2-Targeted Agent-of-Choice and New Standard of Care in First-Line HER2-Positive Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma Notified -